ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
clio
|
7 |
1.2K |
3 |
09:16 |
09:16 |
ASX - By Stock
|
7
|
1.2K
|
3
|
|
ASX - By Stock
|
AXE |
Re:
What is happening
|
|
clio
|
3.2K |
1.4M |
8 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
8
|
|
ASX - By Stock
|
M7T |
Re:
Ann: First Half FY24 Result Presentation
|
|
clio
|
22 |
7.5K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
22
|
7.5K
|
4
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Pause in Trading
|
|
clio
|
21 |
6.7K |
0 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
21
|
6.7K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Pause in Trading
|
|
clio
|
21 |
6.7K |
2 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
21
|
6.7K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Pause in Trading
|
|
clio
|
21 |
6.7K |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
21
|
6.7K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Contracts
|
|
clio
|
19 |
8.0K |
1 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
19
|
8.0K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: FY23 Results Highlights
|
|
clio
|
19 |
8.7K |
1 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
19
|
8.7K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: FY23 Results Highlights
|
|
clio
|
19 |
8.7K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
19
|
8.7K
|
2
|
|
ASX - By Stock
|
CXO |
Re:
News: CXO UPDATE 1-Tesla warns Core Lithium of potential lawsuit over failed deal
|
|
clio
|
121 |
54K |
1 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
121
|
54K
|
1
|
|
ASX - By Stock
|
BAS |
Re:
General discussion thread
|
|
clio
|
4.7K |
1.0M |
3 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
4.7K
|
1.0M
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 selected for Veterans Health Administration Contract
|
|
clio
|
65 |
26K |
2 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
65
|
26K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 selected for Veterans Health Administration Contract
|
|
clio
|
65 |
26K |
4 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
65
|
26K
|
4
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 selected for Veterans Health Administration Contract
|
|
clio
|
65 |
26K |
0 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
65
|
26K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 selected for Veterans Health Administration Contract
|
|
clio
|
65 |
26K |
14 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
65
|
26K
|
14
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 selected for Veterans Health Administration Contract
|
|
clio
|
65 |
26K |
12 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
65
|
26K
|
12
|
|
ASX - By Stock
|
AXE |
Re:
AXE Chart
|
|
clio
|
253 |
108K |
1 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
253
|
108K
|
1
|
|
ASX - By Stock
|
AXE |
Re:
Ann: Qubit material functionality at room temperature in air
|
|
clio
|
88 |
42K |
18 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
88
|
42K
|
18
|
|
ASX - By Stock
|
AXE |
Re:
What is happening
|
|
clio
|
3.2K |
1.4M |
5 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
3.2K
|
1.4M
|
5
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
clio
|
31 |
19K |
0 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
31
|
19K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
TGA Rego Site
|
|
clio
|
53 |
21K |
6 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
53
|
21K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Letter of intent with Sonic Healthcare USA extended
|
|
clio
|
24 |
8.4K |
4 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
24
|
8.4K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
CanSense-CRC test (breakthrough)
|
|
clio
|
14 |
3.4K |
3 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
14
|
3.4K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Institutional Presentation
|
|
clio
|
32 |
7.6K |
2 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
32
|
7.6K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Institutional Presentation
|
|
clio
|
32 |
7.6K |
1 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
32
|
7.6K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Institutional Presentation
|
|
clio
|
32 |
7.6K |
2 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
32
|
7.6K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Latest 2023 KLAS Results - Mach7 - Top 3
|
|
clio
|
6 |
3.0K |
2 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
6
|
3.0K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
clio
|
37 |
7.6K |
6 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
37
|
7.6K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
clio
|
37 |
7.6K |
5 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
37
|
7.6K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
clio
|
37 |
7.6K |
9 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
37
|
7.6K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
clio
|
37 |
7.6K |
4 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
37
|
7.6K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
clio
|
37 |
7.6K |
5 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
37
|
7.6K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Commercialisation of Colostat
|
|
clio
|
22 |
4.9K |
6 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
22
|
4.9K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
TGA Decision
|
|
clio
|
32 |
8.5K |
7 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
32
|
8.5K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Letter of intent with Sonic Healthcare USA extended
|
|
clio
|
24 |
8.4K |
8 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
24
|
8.4K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
|
|
clio
|
12 |
2.6K |
1 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
12
|
2.6K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
clio
|
74 |
18K |
4 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
74
|
18K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
clio
|
74 |
18K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
74
|
18K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
clio
|
12 |
5.9K |
0 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
12
|
5.9K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Investor webinar details - Q2 FY23 Business Update
|
|
clio
|
2 |
1.2K |
1 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
2
|
1.2K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
clio
|
44 |
10K |
0 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
clio
|
44 |
10K |
3 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
clio
|
44 |
10K |
9 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
clio
|
44 |
10K |
11 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
11
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
clio
|
17 |
4.2K |
0 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
17
|
4.2K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
clio
|
17 |
4.2K |
6 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
17
|
4.2K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
clio
|
17 |
4.2K |
1 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
17
|
4.2K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
clio
|
22 |
4.6K |
2 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.6K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
clio
|
39 |
6.8K |
0 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
39
|
6.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
clio
|
39 |
6.8K |
5 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
39
|
6.8K
|
5
|
|